Source: SEC

Surrozen: Surrozen, Inc. raised $76.4M in a Post-IPO Equity round

Read full article »

Surrozen's Competitors | Surrozen's News | Surrozen's Financials

Followers on Owler

538

Annual Revenue

$5.0-25M

Employees

25-100

CEO

Craig Parker

CEO Approval Rating

90/100

Surrozen is a California based biotechnology company that develops and commercializes novel-based therapeutics for stem cell maintenance and tissue regeneration.